Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 21, 2013Record Date for Share Distribution Set for October 21, 2013
The Board of Directors of Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative...
-
Oct 21, 2013Nearly 20 Years of Financial Experience Including Global Operations and Acquisitions Expected to Help Harvard Bioscience Execute Its Growth Strategy
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has hired Robert E....
-
Oct 21, 2013
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that...
-
Dec 11, 2012
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its...
-
Sep 13, 2012
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine,...
-
Jun 26, 2012First Two Transplants Performed in Government-Approved Clinical Trial in Russia
Harvard Bioscience, Inc. (HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that its "InBreath"...
-
Jan 9, 2012
Harvard Bioscience, Inc. (Nasdaq:HBIO), today announced that David Green, President, will be participating in a panel session at the Regenerative Medicine Insight Track at the Biotech Showcase....
-
Nov 29, 2011Collaboration Between HBIO and Nanofiber Solutions Produces U.S.-Made Synthetic Trachea for Procedure in Sweden
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that its...
-
Nov 28, 2011Company Continues to Invest in Regenerative Medicine and Completes Construction of its U.S. Production Facility
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, was highlighted in an...